[1]
S. Ali Hammed and A. Fadhil Alwan, “Metastatic EGFR-Mutant Lung Adenocarcinoma Patients: A Safety and Efficacy Analysis of First- and Third-Generation EGFR-TKIs”, MECOJ, vol. 1, no. 4, pp. 20–25, Dec. 2025, doi: 10.61706/MECOJ160189.